Jim Cramer: These foreign drug stocks are worth betting on over domestics

"If you want big pharma exposure, with fewer headaches related to U.S. politics, you could always buy a well-run foreign drug company," CNBC's Jim Cramer says.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.